H Lundbeck A/S

(HLUKF)

By |

Profile

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs worldwide, including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, and Onfi for epilepsy.

Contact Information

Website: www.lundbeck.com
Email: palo@lundbeck.com
Main Phone: +45 36301311
Address: Ottiliavej 9
City / Town: Valby
Country: DNK
Postal Code: 2500

Issuer Information

Exchange: OTO
Employees: 5119
$ 43.00 $ 0. (0.00%)
Last Price 43.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 43.00
Last Trade Volume 0 52 Wk Hi 73.30 52 Wk Low 39.95
Market Cap 8.6 bi Ex-Div Date Div Rate 1.32 Yield 3.0590
Shares 199,104,996.00 EPS (TTM) 2.97 PE Ratio 14.50 Exchange OTCPK